Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Directly Observed Therapy in High Risk Populations in Newark, NJ

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Saint Michael's Medical Center
ClinicalTrials.gov Identifier:
NCT00285883
First received: January 31, 2006
Last updated: February 27, 2006
Last verified: January 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2006
  Estimated Primary Completion Date: No date given